备注:
 如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
          
       
       
       
       
        
        
详细介绍
 
       
              
          l  基本信息  | 
产品名称  | Dexrazoxane(右雷佐生)  | 
一般描述  | Dexrazoxane is an anticancer drug able to block mitosis and to arrest dividing cells. It is an iron chelator and provides cardioprotection against anthracycline toxicity.  | 
别 称  | ICRF-187; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione  | 
纯 度  | ≥99.0%(HPLC)  | CAS NO.  | 24584-09-6  | 
分子式  | C11H16N4O4  | 分子量  | 268.26914  | 
适用范围  | 生物试剂,适用于细胞培养等  | 
l  理化信息  | 
外 观  | 白色至类白色固体  | 
溶解性(25°C)  | DMSO  | ≥45mg/ml  | 
乙醇  | Insoluble  | 
水  | Very slightly soluble  | 
l  生物学信息  | 
生物活性/药理作用  | Dexrazoxane is a bisdioxopiperazine with iron-chelating, chemoprotective, cardioprotective, and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, limiting the formation of free radical-generating anthracycline-iron complexes, which may minimize anthracycline-ironcomplex-mediated oxidative damage to cardiac and soft tissues. This agent also inhibits the catalytic activity of topoisomerase II, which may result in tumor cell growth inhibition.  | 
l  存储  | 
存储温度  | -20°C  | 
l  注意事项及免责声明  | 
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。  | 
l  参考文献  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |